Tandem Diabetes Care (TNDM) Total Non-Current Liabilities (2013 - 2026)

Tandem Diabetes Care's Total Non-Current Liabilities history runs 14 years deep, the most recent figure standing at $970.6 million for Q1 2026.

• Quarterly Total Non-Current Liabilities rose 33.0% year-over-year to $970.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $970.6 million (up 33.0% YoY) and the FY2025 annual result came in at $676.2 million, up 0.6% from the prior year.
• Total Non-Current Liabilities was $970.6 million for Q1 2026 at Tandem Diabetes Care, up from $676.2 million in the prior quarter.
• Across five years, Total Non-Current Liabilities topped out at $970.6 million in Q1 2026 and bottomed at $560.4 million in Q1 2022.
• A 5-year average of $656.9 million and a median of $665.5 million in 2024 frame the typical range for Total Non-Current Liabilities.
• Annual changes were most pronounced in 2022 — Total Non-Current Liabilities jumped 35.84% — and 2023, when it retreated 0.15%.
• Tandem Diabetes Care's Total Non-Current Liabilities stood at $588.9 million in 2022, then grew by 3.1% to $607.2 million in 2023, then climbed by 10.7% to $672.2 million in 2024, then gained by 0.6% to $676.2 million in 2025, then soared by 43.53% to $970.6 million in 2026.
• Business Quant data shows TNDM's Total Non-Current Liabilities at $970.6 million in Q1 2026, $676.2 million in Q4 2025, and $689.3 million in Q3 2025.